Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Busulfan and Cyclophosphamide with AlloBMT for Hematologic Malignancies
NCT01177371Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Mar 1988
- Primary completion
- Feb 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of busulfan, cyclophosphamide in leukemia, myelodysplastic syndrome (MDS), multiple myeloma (MM), lymphoma, sponsored by Case Comprehensive Cancer Center. Started Mar 1988; status: completed.
02
Drugs
busulfancyclophosphamide
03
Conditions
leukemiamyelodysplastic syndrome (MDS)multiple myeloma (MM)lymphoma
Beyond the preview
Go deeper on NCT01177371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01177371.